Primary carcinoid tumor of the lung
ESHI, in collaboration with MICCAI, is proud to announce the first autoPET challenge on automated tumor lesion segmentation on whole-body FDG-PET/CT. Based on a large-scale, publicly available dataset of 1014 studies, the 7 highest ranking submissions will compete for a total of 15’000€….
The funding priority 2022 is for research in Artificial Intelligence (including quantitative imaging and radiomics) and Interventional oncologic radiology. Proposals at all stages of development are welcome.
The application deadline is March 10, 2022.
Application open until 15 March 2022!
Available centres: LMU Munich / Germany and University of Cambridge / UK
– Happy new year from the ESHIᴹᵀ President
– ESR elections: Ferdia Gallagher for ESR research committe chair
– Membership: Balance your annual fee or become a member in 2022
– Webinar: Watch recordings on a plethora of topics
– Get involved: Share cases, news and stories with the community!
– BNMS Spring Meeting 2022 in Glasgow
4’913 registrations | 2’843 individual live viewers | 1134 parallel viewers on average | 479 questions and comments on Slido
Join the free CHILI Symposium by Bayer on October 29 at 15:30 CEST
Topic: “Value of contrast enhanced CT in hybrid imaging”
Speaker: Prof. Klaus Strobel (Lucerne, Switzerland)
Send us a short clip with you and a chili pepper and we will include you in the breaks of our upcoming conference!
ESHI members benefit of a 50% reduction on registration fees for the European Cancer Summit which will take place on 17 & 18 November, both online and in Brussels.
The summit brings together leading oncology experts, patient advocates, high-level politicians and policy-makers to discuss the main issues impacting cancer policy,
Takayasu arteritis: 18F-FDG-PET/CT